title: Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain.
abstract: The neuropeptide calcitonin gene-related peptide (CGRP) is known to play a pro-nociceptive role after peripheral nerve injury upon its release from primary afferent neurons in preclinical models of neuropathic pain. We previously demonstrated a critical role for spinal cord microglial CD40 in the development of spinal nerve L5 transection (L5Tx)-induced mechanical hypersensitivity. Herein, we investigated whether CGRP is involved in the CD40-mediated behavioral hypersensitivity. First, L5Tx was found to significantly induce CGRP expression in wild-type (WT) mice up to 14 days post-L5Tx. This increase in CGRP expression was reduced in CD40 knockout (KO) mice at day 14 post-L5Tx. Intrathecal injection of the CGRP antagonist CGRP8-37 significantly blocked L5Tx-induced mechanical hypersensitivity. In vitro, CGRP induced glial IL-6 and CCL2 production, and CD40 stimulation added to the effects of CGRP in neonatal glia. Further, there was decreased CCL2 production in CD40 KO mice compared to WT mice 21 days post-L5Tx. However, CGRP8-37 did not significantly affect spinal cord CCL2 production following L5Tx in WT mice. Altogether, these data suggest that CD40 contributes to the maintenance of behavioral hypersensitivity following peripheral nerve injury in part through two distinct pathways, the enhancement of CGRP expression and spinal cord CCL2 production.
authors.affiliation: Department of Microbiology, Biomedical Sciences Section, College of Osteopathic Medicine, University of New England, Biddeford, ME 04005, USA.
authors.forename: Jennifer T
authors.initials: JT
authors.lastname: Malon
authors.forename: Swathi
authors.initials: S
authors.lastname: Maddula
authors.forename: Harmony
authors.initials: H
authors.lastname: Bell
authors.forename: Ling
authors.initials: L
authors.lastname: Cao
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D019013:CD40 Antigens / Q000502:physiology*; D015740:Calcitonin Gene-Related Peptide / Q000096:biosynthesis*; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000096:biosynthesis*; D004195:Disease Models, Animal; D005260:Female; D006930:Hyperalgesia / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D009437:Neuralgia / Q000378:metabolism* / Q000473:pathology; D010147:Pain Measurement / Q000379:methods; D011897:Random Allocation; D013116:Spinal Cord / Q000378:metabolism / Q000473:pathology; D013127:Spinal Nerves / Q000293:injuries / Q000378:metabolism
chemical_list: D019013:CD40 Antigens; C491768:Ccl2 protein, mouse; D018932:Chemokine CCL2; D015740:Calcitonin Gene-Related Peptide